The state legislature is mulling over the passage of two bills: one that would eliminate Ballad’s status as a protected monopoly, and another that would remove the Certificate of Need, a barrier that forces healthcare entities to submit expansion proposals to regulators for approval. The issue, the FTC says, is related to timing.
The Centers for Medicare & Medicaid Services unveiled a new program for alternative payment model participants that would allow clinicians to use products containing CBD as part of patient care plans. In response, the Food and Drug Administration vowed not to further restrict the sale of oral hemp products.
A convolutional neural network has proven adept at predicting the spread of colorectal cancer to the lymph nodes using automated analysis of histology slides.
Aimed at food manufacturers, chain restaurants and food service operators, the document offers target sodium levels for some 163 categories of processed, prepared and packaged foods.
A systematic review of 57 studies representing more than a quarter-million COVID cases has turned up some distressing statistics on survivors—not least those considered “long-haulers.”
A reversal in COVID telehealth reimbursement could further demoralize a medical specialty that has arguably carried more than its own weight during the public health crisis.
